<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Purpose:  Patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) have an increased risk of developing <z:hpo ids='HP_0001250'>seizures</z:hpo> or <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Little is known about the role of risk factors and about the risk of developing <z:hpo ids='HP_0001250'>seizures</z:hpo>/<z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> in patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to assess incidence rates (IRs) of <z:hpo ids='HP_0001250'>seizures</z:hpo>/<z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> in patients with AD, VD, or without <z:hpo ids='HP_0000726'>dementia</z:hpo>, and to identify potential risk factors of <z:hpo ids='HP_0001250'>seizures</z:hpo> or <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Methods:  We conducted a follow-up study with a nested case-control analysis using the United Kingdom-based General Practice Research Database (GPRD) </plain></SENT>
<SENT sid="4" pm="."><plain>We identified patients aged ≥65 years with an incident diagnosis of AD or VD between 1998 and 2008 and a matched comparison group of <z:hpo ids='HP_0000726'>dementia</z:hpo>-free patients </plain></SENT>
<SENT sid="5" pm="."><plain>Conditional logistic regression was used to estimate the odds ratio (OR) with a 95% confidence interval (CI) of developing <z:hpo ids='HP_0001250'>seizures</z:hpo>/<z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> in patients with AD or VD, stratified by age at <z:hpo ids='HP_0003674'>onset</z:hpo> and duration of <z:hpo ids='HP_0000726'>dementia</z:hpo> as well as by use of antidementia drugs </plain></SENT>
<SENT sid="6" pm="."><plain>Key Findings:  Among 7,086 cases with AD, 4,438 with VD, and 11,524 matched <z:hpo ids='HP_0000726'>dementia</z:hpo>-free patients, we identified 180 cases with an incident diagnosis of <z:hpo ids='HP_0001250'>seizures</z:hpo>/<z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The IRs of <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>/<z:hpo ids='HP_0001250'>seizures</z:hpo> for patients with AD or VD were 5.6/1,000 person-years (py) (95% CI 4.6-6.9) and 7.5/1,000 py (95% CI 5.7-9.7), respectively, and 0.8/1,000 py (95% CI 0.6-1.1) in the <z:hpo ids='HP_0000726'>dementia</z:hpo>-free group </plain></SENT>
<SENT sid="8" pm="."><plain>In the nested case-control analysis, patients with longer standing (≥3 years) AD had a slightly higher risk of developing <z:hpo ids='HP_0001250'>seizures</z:hpo> or <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> than those with a shorter disease duration, whereas in patients with VD the contrary was observed </plain></SENT>
<SENT sid="9" pm="."><plain>Significance:  <z:hpo ids='HP_0001250'>Seizures</z:hpo> or <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> were substantially more common in patients with AD and VD than in <z:hpo ids='HP_0000726'>dementia</z:hpo>-free patients </plain></SENT>
<SENT sid="10" pm="."><plain>The role of disease duration as a risk factor for <z:hpo ids='HP_0001250'>seizures</z:hpo>/<z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> seems to differ between AD and VD </plain></SENT>
</text></document>